Received Mar 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
arm where I received the injection was hard, red and swollen; arm where I received the injection was hard, red and swollen; arm where I received the injection was hard, red and swollen; This Spontaneous report was received from a Physician of unknown age reporting on himself. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On an unknown date, patient received a dose of Pneumococcal 21-valent Conjugate Vaccine Solution for injection (CAPVAXIVE) Unknown Batch/Lot Number, for prophylaxis (unknown route, dose and vaccination site). The patient reported that the arm where he received the injection was hard, red and swollen (Vaccination site erythema, Vaccination site swelling and Vaccination site induration). It was unknown if the patient sought medical attention or received any treatment for the events. At the time of reporting, the patient was recovering from above-mentioned events. The action taken with Pneumococcal 21-valent Conjugate Vaccine Solution for injection 114412038:4347 regarding Vaccination site induration was Not applicable with Not Applicable dechallenge and rechallenge results. The Physician did not provide the causality assessment for the events to Pneumococcal 21-valent Conjugate Vaccine Solution for injection (CAPVAXIVE). The Physician considered the events to be non-serious.